Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Steuber

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Blood|June 15, 1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group studyM B Harris, J J Shuster, A Carroll, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group studyS J Kuerbitz, C I Civin, J P Krischer, et al.
Medical and Pediatric Oncology|January 1, 1989
Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group StudyJ P Krischer, C P Steuber, T J Vietti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemiaC H Pui, S C Raimondi, M J Borowitz, et al.
Blood|February 1, 1991
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 casesC H Pui, L S Frankel, A J Carroll, et al.
Blood|February 3, 1998
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group studyS P Hunger, M Z Fall, B M Camitta, et al.
The Journal of Pediatrics|April 1, 1980
X-linked lymphoproliferative syndrome registry reportJ K Hamilton, L A Paquin, J L Sullivan, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Blood|June 15, 1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group studyM B Harris, J J Shuster, A Carroll, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group studyS J Kuerbitz, C I Civin, J P Krischer, et al.
Medical and Pediatric Oncology|January 1, 1989
Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group StudyJ P Krischer, C P Steuber, T J Vietti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemiaC H Pui, S C Raimondi, M J Borowitz, et al.
Blood|February 1, 1991
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 casesC H Pui, L S Frankel, A J Carroll, et al.
Blood|February 3, 1998
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group studyS P Hunger, M Z Fall, B M Camitta, et al.
The Journal of Pediatrics|April 1, 1980
X-linked lymphoproliferative syndrome registry reportJ K Hamilton, L A Paquin, J L Sullivan, et al.
Pageof 7